Navigation Links
Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
Date:10/18/2007

BURLINGTON, Mass., Oct. 18 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading developer of laser- and light- based devices for hair removal and other cosmetic treatments, will hold its quarterly conference call of its 2007 third quarter financial results on Thursday, October 25, 2007 at 11:30AM Eastern Time. If you would like to participate, please call (800) 573-4842 at 11:20 AM Eastern Time on that day. The telephone replay will be available one hour after the call at (888) 286- 8010 passcode 92336806 and continue through Thursday, November 8, 2007.

A live webcast of Palomar's conference call will be available in the Investor Relations' section of the Company's web site http://www.palomarmedical.com. Institutional investors can access the call via Thomson Financial's password- protected event management site, StreetEvents (http://www.streetevents.com). The online archive will be available immediately after the call and continue through Thursday, November 8, 2007.

For more information on Palomar and its products, visit Palomar's website at http://www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.

About Palomar Medical Technologies, Inc: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-power
'/>"/>

SOURCE Palomar Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...TON-SALEM, N.C. Free drug samples provided to phy... be costing uninsured patients more in the long ru...e Forest University Baptist Medical Center and col... prescribing habits of more than 70 physicians in ... in the months immediately before and after the cl...
(Date:9/4/2008)...PAIGN, Ill. Many older Americans may be shortchan...urity too soon, according to a University of Illin...program for nearly two decades. , More than thre...l Security checks for life by claiming benefits ea...erstood the program,s options and consequences, la...
(Date:9/4/2008)...als want stronger labeling about fungal infection ...ews) -- Federal health authorities have asked the ...e drugs to bolster safety warnings on the risk of ...he drugs, Humira, Cimzia, Enbrel and Remicade, bel...sis factor alpha blockers (TNF-alpha blockers), wh...
(Date:9/4/2008)...CIFIC PALISADES, Calif., Sept. 4 /PRNewswire/ -- M...cognized authority in the field of weight,control ...Who in,California," "Who,s Who in The West," "Who,...s Who in Medicine and Health Care" and other honor...s expertise to exposing the,inaccurate, misleading...
Breaking Medicine News(10 mins):Health News:Free drug samples may end up costing uninsured more 2Health News:Free drug samples may end up costing uninsured more 3Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...formula Gentlease is being recalled from the marke... of metal particles in some cans. // So this brand... Gentlease powdered infant formula, Mead Johnson N...itiated the voluntary recall of 24-ounce cans with...
... in France are on tenterhooks, preventing the spre... exist on a turkey farm in the Eastern past of Fra...witnessed the illness of many turkeys, was just 20...ks were among the first to get the bird flu virus ...
...us disease expert has warned against indiscriminat...ibiotics Australians use ,are prescribed inappropr... Australian Society for Antimicrobials annual scie...robiologist John Turnidge, of the Adelaide Women's...
...e, a potential post-operative complication followi... prevented by provision of xenon gas, a new study ...l clinical trial can be found in Anesthesiology jo...dministered xenon gas safely to a group of 12 pati...
Other Medicine News:
(Date:9/5/2008)... Calif., Sept. 5 /- SARcode...olecule LFA-1 inhibitors,to treat inflammatory dis...SNSS) today announced SARcode,s initiation of a Ph...duct candidate for T-cell mediated ophthalmic,dise...greement providing,SARcode with an exclusive licen...
(Date:9/4/2008)...ept. 4 /- BioForm Medical,...otal clinical study of,Polidocanol, conducted in G...rik KREUSSLER & Co. GmbH (Kreussler), successfully...tted to FDA as part of a New Drug Application,(NDA...the EASI (Efficacy and safety of,Aethoxysklerol co...
(Date:9/4/2008)...Enroll 750 Women at More Than 100 Sites in the U.S...Rx Pharmaceuticals, a,privately-held biopharmaceut...ization of compounds to treat endocrine, metabolic...t it has initiated a second,Phase 3 clinical trial...,estrogen-free oral therapy in development for the...
(Date:9/4/2008)...main on Schedule with Two Abstracts Accepted for ...n November 2008, BRIDGEWATER, N.J., Sept. 4 /PRNe...alty pharmaceutical company focused on the treatme...announced the appointment of,Peter L. Garrambone, ...arrambone,s career includes more than 50 pharmaceu...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 474 1Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 474 2Celebrity Seating Only 21 Levitz Chair Signed by 39 Daytime Stars Sells for 241200 on Charitybuzz com 469 1Celebrity Seating Only 21 Levitz Chair Signed by 39 Daytime Stars Sells for 241200 on Charitybuzz com 469 2BSP Pharma Inc Makers of FlexNow 28TM 29 Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC 339 1BSP Pharma Inc Makers of FlexNow 28TM 29 Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC 339 2No Sheet 3A New Disposable Cover Keeps Bed Bugs at Bay 462 1No Sheet 3A New Disposable Cover Keeps Bed Bugs at Bay 462 2No Sheet 3A New Disposable Cover Keeps Bed Bugs at Bay 462 3
...Conn., April 19, 2007 /PRNewswire-FirstCall/ --,Cu...ay that,preliminary interim clinical data on intra...(HDAC) inhibitor being investigated,for the treatm...,upcoming major medical meetings. , One oral and o...,results with belinostat will be made at the 2007 ...
...Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Critical,Th...at new,preclinical research demonstrating a role i... Mobility Group Box-1 protein (HMGB1), a,pro-infla...will be,published in the May 2007 issue of Nature ...1 is part of DNA complexes that,can stimulate immu...
Other Medicine Technology:CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
Hudson-Downs Burr
McKenzie Perforator Drill
Cushing Perforator Drill
Self retaining brain retractor.
Medicine Products: